Downing O A, Stein W, Wilson K A, Wilson V G
Department of Pharmaceutical Sciences, University of Aston, Birmingham, England.
Naunyn Schmiedebergs Arch Pharmacol. 1988 Sep;338(3):239-45. doi: 10.1007/BF00173394.
The pharmacological characteristics of post-junctional alpha-adrenoceptors mediating contractions of the longitudinal smooth muscle of the rat isolated portal vein have been examined. Responses to the noncumulative addition of either noradrenaline, or the selective alpha 2-adrenoceptor agonist UK-14,304, were equally sensitive to a low concentration (0.005 mumol/l) of prazosin. Idazoxan (0.1 mumol/l-0.5 mumol/l), a selective alpha 2-adrenoceptor antagonist, was less potent than prazosin against both agonists. The combination of 0.1 mumol/l idazoxan and 0.125 mumol/l prazosin failed to produce a greater inhibition of responses to UK-14,304 than 0.125 mumol/l prazosin alone. A study involving the effect of various antagonists against a single concentration producing a submaximal response to UK-14,304, provided evidence for a prazosin-resistant component of responses which was sensitive to phentolamine. This component could, therefore, be attributed to an alpha-adrenoceptor. However, this particular response could not be ascribed to stimulation of an alpha 2-subtype since the selective alpha 1-adrenoceptor antagonist, corynanthine, produced greater inhibition than the selective alpha 2-adrenoceptor diastereoisomer rauwolscine.